J&J previously settled most of the cases alleging that its talc contained asbestos and caused mesothelioma. Plaintiffs’ law firms confirmed the deal Monday, saying it was a good resolution after a decade-long court battle. The deal must be accepted by 95% of the ovarian cancer claimants in state or federal court before it becomes final. Chris Seeger, an attorney who represents about 2,500 clients with talc claims and helped negotiate the agreement, said J&J could ultimately pay $7 billion or more. J&J has long denied that its talc products caused cancer, saying that talc was safe and did not contain asbestos.